Increased Survival after Treatment of Canine Hemangiosarcoma with Fenofibrate

<p>Hemangiosarcoma (HSA) is a common and highly metastatic tumor that affects predominantly large-breed dogs. The median survival time for dogs diagnosed with splenic HSA without adjuvant chemotherapy after surgery is 86 days. Fenofibrate is an FDA-approved drug commonly utilized to treat high...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Johanna K Ecke (Author), Luis Del Valle (Author), Amanda Parker Struckhoff (Author), Piotr Waligorski (Author), Krzysztof Reiss (Author), Francesca Peruzzi (Author)
Format: Knjiga
Izdano: International Journal of Veterinary Science and Research - Peertechz Publications, 2015-10-16.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto